X MOLECULAR
CYTOPATHOLOGY
Congress Center “Federico II” Napoli – Italy
6th / 7th DECEMBER 2021
Organized by
Giancarlo Troncone
Sinchita Roy-Chowdhuri
Maria D. Lozano
Organizing Secretariat
Concerto Srl
Ph + 39 081.19569195
E-mail: info@concertosrl.net
Dead line: 4th December 2021 (at 00:00 CET time)
With the Patronage of:
Selected Highlights from “The IX Molecular Cytopathology Meeting”
It is with great pride and honour for me to invite you to the X Edition of the Molecular Cytopathology Congress.
This International Congress, started as a focus on a diagnostic niche in the cytopathology field, has growth along with the introduction of an increasingly number of molecular tests for predictive and diagnostic purpose.
Moreover, the introduction of these new molecular techniques has challenged our daily routine practice that has shifted from a microscopic-only approach to a multidisciplinary one, in which the molecular biologist has become a valuable partner in the diagnostic work-up.
The X Edition of Molecular Cytopathology Congress will provide a perspective on the evolution of molecular pathology in the field of cytopathology with updates on cytological and molecular classifications.
Due to the Covid pandemic, this year meeting will include live and on-line sessions from experts around the world.
THE MEETING DIRECTOR:
Prof. Giancarlo Troncone
PROGRAM
Program according to CET (Central European Time)
Pacific Time (PT): Los Angeles -9 hrs
Central Time (CT): Chicago -7 hrs
Eastern Time (ET): New York -6 hrs
6th DECEMBER 2021
INTRODUCTION
09:30 AM Ten years of Molecular Cytgopathology
Giancarlo Troncone
Chairmen: Sinchita Roy-Chowdhuri – Maria D. Lozano
SESSION I: COVID-19 session
Chairman: Syed Z. Ali
10:00 AM
The state of cytopathology laboratories during the COVID-19 pandemic
Elena Vigliar
10:30 AM
Clinical and molecular practice of European thoracic pathology laboratorie during the COVID-19 pandemic. The past and the near future
Paul Hofman
11:00 AM
Questions & Answers
11:30 AM
Break
Session II Molecular Thyroid Cytopathology – First part
Chairman: Ester D. Rossi
12:00 AM The Emerging and Expanded Role of Molecular Testing in Thyroid Cytopathology
Syed Z. Ali
12:30 PM The persisting dilemma of AUS/FLUS (Tir3A)
Massimo Bongiovanni
1:00 PM Questions & Answers
1:30 PM Break
Session III Molecular Thyroid Cytopathology – Second part
Chairman: Ester D. Rossi
2:30 PM NGS technology to refine uncertain thyroid cytological diagnosis
Claudio Bellevicine
3:00 PM Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)
William C. Faquin
3.30 – 4.00 PM Questions & Answers
Session IV Ancillary Testing in Head and Neck Cytology
3.30 PM Chairman: William C. Faquin
4.00 PM Challenges facing Pathologists Evaluating PD-L1 in Head & Neck Squamous Cell Carcinoma
Massimo Barberis
4.30 PM Molecular Landscape of Salivary Gland Cytology (MSRSGC) in the Era of Personalized Medicine
Zahra Maleki
5.00 PM Updates and news from the II edition of MSRTC: is there a place for molecular tests?
Ester D. Rossi
5.30- 6.00 PM Questions & Answers
7th DECEMBER 2021
Session V Lung Cytopathology - First part
Chairman: Lukas Bubendorf
9.30 AM WHO-IA RC International System for Reporting Lung Cytopathology
Fernando Schmitt
10:00 AM PD-L1 testing of non-small cell lung cancer on cytological specimens
Maria D. Lozano
10:30 AM Questions & Answers
11:00 AM Break
Session VI Lung Cytopathology – Second part
Chairman: Philippe Vielh
11:30 AM RNA Fusion Assays Using Next-Generation Sequencing
Sinchita Roy-Chowdhuri
12:00 AM Liquid biopsy
Umberto Malapelle
12:30 AM Assessment of tumor mutational burden in cytological specimens from lung cancer patients
Spasenija Savic
1:00 PM Questions & Answers
1:30 PM Break
Session VII Urine cytology
Chairman: Fernando Schmitt
2:30 PM The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH
Lukas Bubendorf
3:00 PM Digital Pathology & Artificial Intelligence applied to urine cytopathology
Liron Pantanowitz
Session VII Urine cytology
Why cytologists should take the small diagnostic urothelial biopsies from surgical pathologists
Fischer AH.
4:00 PM Questions & Answers
Session VIII Molecular cytopathology slide seminar
4:30 PM How molecular tests has improved my diagnostic routine
Philippe Vielh and Faculty
5:30 PM Questions & Answers
6.00 PM Closing remarks
Giancarlo Troncone
Sinchita Roy-Chowdhuri
Maria D. Lozano
GENERAL INFO
Meeting “in presence”:
Venue: Congress Centre “Federico II” Via Partenope, 36 – Naples, ITALY
Meeting “on-line”:
Virtual meeting on Zoom platform.
It is strongly recommended to download and install zoom in advance. The installer is available at https://zoom.us/download.
Registered participants to attend the virtual meeting will receive an e-mail containing Zoom link and password.
Official language:
English – NO simultaneous translation
Recording:
The full meeting will be recorded and made available for later viewing for six months after the end of the meeting, only to attendees.
ECM credits:
The event will grant 14 ECM credits only for those attending “in presence”.
Registration:
Meeting fee: IN PRESENCE* € 120,00 (VAT included)
Meeting fee: ON-LINE** € 60,00 (VAT included)
Meeting fee reduced for residents (ON-LINE only): **
(proof of residency required) € 30,00 (VAT included)
* Registration fee includes: access to the scientific sessions, conference bag, buffet lunches and refreshments (where envisaged), certificate of attendance, ECM certificate (Italian participants – in case of credits achievement).
**Registration fee includes: meeting on line, certificate of attendance. No ECM credits for the on-line meeting.
Your registration will be confirmed on receipt of the full payment.
Payment should be made on line by credit card (VISA, Mastercard/Eurocard, American Express) or bank transfer.
Dead line: 4th December 2021 (at 00:00 CET time)
Cancellation policy:
Cancellations should be received in writing to the Organizing Secretariat.
Cancellations received before 30th October 2021 (at 00:00 CET time) – full refund less 10% to cover administration costs.
No refund for cancellation received after 30th October 2021 (at 00:00 CET time) or no show.
Refunds, net of any bank charges, will be processed after the end of the Meeting.
In the unlikely case that the Congress cannot be held in whole or in part due to any event beyond the Organisers’ control or force majeure (such as riot, fire, explosion, accident, flood, earthquake, sabotage, strikes, acts of law or regulation by Italian or foreign Authorities, epidemic outbreak, sanitary emergency, etc) the Congress Organisers cannot be held liable for any damage, cost, or loss incurred, such as registration fee, transportation and accommodation costs, or any other direct or indirect loss or consequential damage.
Dead line: 4th December 2021 (at 00:00 CET time)
FACULTY
Syed Z. Ali
MD, FRCPath, FIAC
Baltimore, MD – USA
Professor of Pathology and Radiology
Director of Cytopathology
The Johns Hopkins Hospital -Baltimore, MD
Massimo C.P. Barberis
MD
Milano, Italy
Director
Clinical Unit of Histopathology and Molecular Diagnostics
European Institute of Oncology, IRCCS, Milano
Claudio Bellevicine
MD, PhD
Naples – Italy
Assistant Professor of Anatomic Pathology,
Department of Public Health, University of Naples Federico II
Massimo Bongiovanni
MD, MIAC
Lausanne, Switzerland
Pathologist and Cytopathologist
Director of Cytopathology at Synlab Pathology
Lukas Bubendorf
MD, Surgical Pathologist and Cytopathologist
Basel – Switzerland
Head of Cytopathology, Institute of Molecular Genetics and Pathology, University Hospital Basel
William C. Faquin
MD, PhD
Boston, Massachusetts – USA
Professor of Pathology
Massachusetts General Hospital and Harvard Medical School
Director of Head and Neck Pathology
Massachusetts Eye and Ear
Andrew Henry Fischer
MD, PhD
Worcester, MA – USA
Professor of Pathology
Professor of Radiology
University of Massachusetts Medical School, Worcester, MA
Paul Hofman
MD, PhD
Nice – France
Professor of Pathology, Laboratory of Clinical and Experimental Pathology
Côte d’Azur University, Nice
Maria D. Lozano
MD, PhD, MIAC
Pamplona – Spain
Professor of Pathology, Director Department Of Pathology
Clinica University of Navarra
Umberto Malapelle
PhD
Naples – Italy
Chief Supervisor of Predictive Molecular Pathology Lab, Department of Public Health, University of Naples Federico II
Zahra Maleki
MD, FCAP, MIAC
Baltimore, MD – USA
Associate Professor of Pathology – Department of Pathology, Division of Cytopathology Johns Hopkins Hospital
Liron Pantanowitz
MD MHA
Ann Arbor, MI – USA
Director of Anatomic Pathology
Professor of Pathology – Department of Pathology & Clinical Labs University of Michigan
Esther D. Rossi
MD, PhD
Rome, Italy
Aggregate professor of Anatomic Pathology
Fondazione Policlinico Universitario Agostino Gemelli. IRCCS
Sinchita Roy-Chowdhuri
MD, PhD
Houston ,Texas – USA
Associate Professor Department of Pathology, UT M.D. Anderson Cancer Center
Spasenija Savic Prince
MD – Pathology (FMH) Cytopathology
Basel – Switzerland
Senior pathologist, Institute for Medical Genetics and Pathology University Hospital Basel
Fernando C. Schmitt
MD, PhD, FIAC
Porto – Portugal
Professor of Pathology at Medical Faculty of Porto University
Coordinator of RISE – Health Research Network
Head Molecular Pathology Unit, IPATIMUP
Member of Standing Committee WHO Cytopathology Reporting Systems
General Secretary of the International Academy of Pathology
Giancarlo Troncone
MD, PhD
Naples – Italy
Full Professor of Anatomic Pathology, Department of Public Health, University of Naples Federico II
Philippe Vielh
MD, PhD, FIAC
Paris – France
Medipath and American Hospital of Paris
Elena Vigliar
MD, PhD
Naples – Italy
Assistant Professor of Anatomic Pathology, Department of Public Health, University of Naples Federico II
Dead line: 4th December 2021 (at 00:00 CET time)
